Deer Management Co. LLC T Scan Therapeutics, Inc. Transaction History
Deer Management Co. LLC
- $214 Million
- Q1 2025
A detailed history of Deer Management Co. LLC transactions in T Scan Therapeutics, Inc. stock. As of the latest transaction made, Deer Management Co. LLC holds 1,245,504 shares of TCRX stock, worth $2.34 Million. This represents 0.8% of its overall portfolio holdings.
Number of Shares
1,245,504
Previous 1,245,504
-0.0%
Holding current value
$2.34 Million
Previous $3.76 Million
54.32%
% of portfolio
0.8%
Previous 1.11%
Shares
2 transactions
Others Institutions Holding TCRX
# of Institutions
92Shares Held
39.8MCall Options Held
0Put Options Held
0-
Lynx1 Capital Management LP San Juan, PR5.36MShares$10.1 Million2.73% of portfolio
-
Bvf Inc San Francisco, CA4.89MShares$9.19 Million0.3% of portfolio
-
Black Rock Inc. New York, NY4.46MShares$8.39 Million0.0% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA3.5MShares$6.58 Million0.01% of portfolio
-
Baker Bros. Advisors LP New York, NY2.78MShares$5.24 Million0.05% of portfolio
About TScan Therapeutics, Inc.
- Ticker TCRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 18,929,800
- Market Cap $35.6M
- Description
- TScan Therapeutics, Inc., a preclinical-stage biopharmaceutical company, develops T cell receptor-engineered T cell therapies for the treatment of patients with cancer. It is developing TSC-100 and TSC-101 for the treatment of patients with hematologic malignancies to eliminate residual leukemia and prevent relapse after hematopoietic stem cell ...